SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-19-000155
Filing Date
2019-01-03
Accepted
2019-01-03 17:24:25
Documents
5
Group Members
CGY INVESTMENTSSENG FUN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d0119acgyinvest_aptorum.htm SC 13D 126684
2 JOINT FILING AGREEMENT, DATED JANUARY 3, 2019 sc13d0119aex99-1cgyin_apto.htm EX-99.1 8223
3 SERIES A SUBSCRIPTION AGREEMENT BETWEEN APTUS HOLDING LIMITED AND CGY INVESTMENT sc13d0119aex99-2cgyin_apto.htm EX-99.2 155016
4 SHARE TRANSFER AGREEMENT BETWEEN CGY INVESTMENTS LIMITED AND JURCHEN INVESTMENT sc13d0119aex99-3cgyin_apto.htm EX-99.3 18945
5 SHARE PURCHASE AGREEMENT BETWEEN CGY INVESTMENTS LIMITED AND JURCHEN INVESTMENT sc13d0119aex99-4cgyin_apto.htm EX-99.4 8682
  Complete submission text file 0001213900-19-000155.txt   318956
Mailing Address 17/F, GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL HONG KONG F4 999077
Business Address 17/F, GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL HONG KONG F4 999077 852 2117 6611
Aptorum Group Ltd (Subject) CIK: 0001734005 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90757 | Film No.: 19507074
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17/F, GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL HONG KONG F4 999077
Business Address
Lui Darren (Filed by) CIK: 0001762837 (see all company filings)

Type: SC 13D